18F-PSMA-1007 PET/CT联合血清总前列腺特异性抗原预测前列腺癌ISUP病理分级的临床价值
回顾性分析117例前列腺癌初诊患者,探讨18F-PSMA-1007 PET/CT参数及血清tPSA与ISUP病理分级的相关性。TSR和血清tPSA是ISUP分级的独立影响因素,PET/CT参数SUVmax和TSR预测高低级别分组的AUC分别为0.800和0.797。
要点
- SUVmax、TSR、血清tPSA与ISUP病理分级均呈正相关(r分别为0.640、0.619和0.500,均P<0.01)。
- 多因素分析显示TSR(OR=4.172)和血清tPSA(OR=1.042)是ISUP分级的独立影响因素。
- 行根治术的70例中,ISUP高级别患者术后复发率54.8%(17/31)高于低级别患者25.6%(10/39)。
核心结论
- 18F-PSMA-1007 PET/CT在预测前列腺癌ISUP病理分级方面具有良好的应用价值。
- 血清tPSA和TSR是预测前列腺癌ISUP病理分级有价值的因素。
研究设计与样本
- 回顾性分析2018年8月至2024年2月经山西省肿瘤医院病理科确诊并行18F-PSMA-1007 PET/CT显像的117例前列腺癌初诊患者。
- 采用单因素和多因素logistic回归分析明确ISUP病理分级的独立影响因素,采用ROC曲线评价PET/CT主要参数预测ISUP高级别与低级别分组的效能。
主要发现
- 117例中ISUP1级20例、2级25例、3级18例、4级32例、5级22例;低级别组(1-3级)63例,高级别组(4-5级)54例。
- 117例肿瘤长径3.10(2.05,4.25)cm,前列腺体积40.11(33.13,51.85)cm3,血清tPSA 19.71(12.25,42.83)ng/ml,PSAD 0.51(0.31,1.01)ng·ml-1·cm-3,SUVmax 15.24(10.87,22.03),TSR 1.61(1.08,2.15)。
- SUVmax、TSR、血清tPSA与ISUP病理分级均呈正相关(r分别为0.640、0.619和0.500,均P<0.01)。
- 五个ISUP级别组间肿瘤长径、血清tPSA、PSAD、病灶SUVmax、TSR差异均有统计学意义(均P<0.001);低级别组与高级别组间上述指标差异也均有统计学意义(均P<0.01)。
- 行前列腺癌根治术的70例患者中,ISUP高级别患者术后复发率为54.8%(17/31),高于ISUP低级别患者(25.6%,10/39;χ2=6.21,P<0.05)。
关键数值与推荐
- 多因素logistic回归显示血清tPSA(OR=1.042,95% CI:1.014~1.070,P<0.01)和TSR(OR=4.172,95% CI:2.095~8.308,P<0.001)是前列腺癌ISUP病理分级分组的独立影响因素。
- ROC分析显示SUVmax预测ISUP低级别或高级别的AUC为0.800(95% CI:0.717~0.883),TSR的AUC为0.797(95% CI:0.713~0.881)。
临床怎么用
- 原文结论为18F-PSMA-1007 PET/CT在预测前列腺癌ISUP病理分级方面具有良好的应用价值,血清tPSA和TSR是预测ISUP病理分级有价值的因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To discuss the correlation of International Society of Urological Pathology (ISUP) pathological grading with18F-prostate specific membrane antigen (PSMA)-1007 positron emission tomography-computed tomography (PET/CT) parameters and serum total prostate specific antigen (tPSA) in prostate cancer, and assess the clinical value of PET/CT combined with tPSA in predicting the ISUP pathological grade of prostate cancer. Methods: The correlation of ISUP pathological grade with primary parameters of PET/CT images and serum tPSA of 117 patients diagnosed with prostate cancer at Shanxi Cancer Hospital from August 2018 to February 2023 and taken 18F-PSMA-1007 PET/CT imaging were retrospectively analyzed. Univariate and multivariate logistic regressions were used to identify the independent influencing factors for ISUP pathological grading of prostate cancer. The receiver operating characteristic (ROC) curves were used to predict the efficacy between the high and low ISUP grades for prostate cancer. Results: Of the 117 patients, 20 were in ISUP Group 1, 25 in Group 2, 18 in Group 3, 32 in Group 4, and 22 in Group 5. Of these, 63 were in the low-grade group (Groups 1-3) and 54 were in the high-grade group (Groups 4-5). The tumor long diameter was 3.10 (2.05, 4.25) cm, the prostate volume was 40.11 (33.13, 51.85) cm3, the serum tPSA was 19.71 (12.25, 42.83) ng/ml, the prostate specific antigen density (PSAD) was 0.51 (0.31, 1.01) ng·ml-1·cm-3, the maximum standard uptake value of the lesion (SUVmax) was 15.24 (10.87, 22.03), and the tumor/spleen uptake ratio (TSR) was 1.61 (1.08, 2.15) in the 117 patients. The correlation analysis displayed that the SUVmax, TSR, and tPSA were positively correlated with ISUP groups (r=0.640, 0.619, and 0.500, P<0.01). The differences among SUVmax, TSR, long diameter, tPSA, and PSAD were statistically significant when compared among the five ISUP groups (H=48.98, 45.63, 26.82, 33.95, and 23.81, P<0.001). The differencesin serum tPSA (z=5.19), PSAD (z=4.64), long diameter (z=3.19), SUVmax (z=5.57), and TSR (z=5.53) of the patients between the low-grade group and the high-grade group were statistically significant (P<0.01). In multivariate analysis, TSR (OR=4.172, 95% CI: 2.095-8.308, P<0.001) and the serum tPSA (OR=1.042, 95% CI: 1.014-1.070, P<0.01) were independent influencing factors for ISUP grades. ROC analysis revealed that the area under the curve for the 18F-PSMA-1007 PET/CT parameters SUVmax and TSR to predict low- or high-grade ISUP for prostate cancer was 0.800 (95% CI: 0.717-0.883) and 0.797 (95% CI: 0.713-0.881), respectively. Among the 70 patients who underwent radical prostatectomy, the postoperative recurrence rate of high-grade ISUP patients was higher than that of low-grade patients (54.8% and 25.6%, χ2=6.21, P<0.05). Conclusions: 18F-PSMA-1007 PET/CT has good application in predicting ISUP grading of prostate cancer. TSR and the serum tPSA are independent predictors for the pathological grade. 目的: 探讨前列腺癌国际泌尿病理协会(ISUP)病理分级与18F-前列腺特异性膜抗原(PSMA)-1007 PET/CT参数和血清前列腺总特异性抗原(tPSA)的相关性,评价通过18F-PSMA-1007 PET/CT预测前列腺癌ISUP病理分级的临床价值。 方法: 回顾性分析2018年8月至2024年2月经山西省肿瘤医院病理科确诊并行18F-PSMA-1007 PET/CT显像的117例前列腺癌初诊患者ISUP病理分级与PET/CT主要参数和tPSA的相关性。采用单因素和多因素logistic回归分析明确前列腺癌ISUP病理分级的独立影响因素,采用受试者工作特征(ROC)曲线评价18F-PSMA-1007 PET/CT图像主要参数预测前列腺癌ISUP高级别与低级别分组的效能。 结果: 117例患者中,ISUP病理分级为ISUP1级20例,ISUP2级25例,ISUP3级18例,ISUP4级32例,ISUP5级22例;低级别组63例,高级别组54例。117例患者的肿瘤长径为3.10(2.05,4.25)cm,前列腺体积为40.11(33.13,51.85)cm3,tPSA为19.71(12.25,42.83)ng/ml,前列腺特异性抗原密度(PSAD)为0.51(0.31,1.01)ng·ml-1·cm-3,病灶最大标准摄取值(SUVmax)为15.24(10.87,22.03),肿瘤/脾脏摄取比值(TSR)为1.61(1.08,2.15)。相关分析显示,SUVmax、TSR、血清tPSA与ISUP病理分级均呈正相关(r分别为0.640、0.619和0.500,均P<0.01)。ISUP1级组、ISUP2级组、ISUP3级组、ISUP4级组和ISUP5级组的肿瘤长径、血清tPSA、PSAD、病灶SUVmax、TSR差异均有统计学意义(均P<0.001),低级别组与高级别组患者的肿瘤长径、血清tPSA、PSAD、病灶SUVmax、TSR差异也均有统计学意义(均P<0.01)。多因素logistic回归分析显示,血清tPSA(OR=1.042,95% CI:1.014~1.070)和TSR(OR=4.172,95% CI:2.095~8.308)是前列腺癌ISUP病理分级分组的独立影响因素。ROC分析显示,18F-PSMA-1007 PET/CT参数SUVmax、TSR预测前列腺癌ISUP低级别或高级别的曲线下面积分别为0.800(95% CI:0.717~0.883)和0.797(95% CI:0.713~0.881)。行前列腺癌根治术的70例患者中,ISUP高级别患者术后复发率为54.8%(17/31),高于ISUP低级别患者(25.6%,10/39;P<0.05)。 结论: 18F-PSMA-1007 PET/CT在预测前列腺癌ISUP病理分级方面具有良好的应用价值,血清tPSA和TSR是预测前列腺癌ISUP病理分级有价值的因素。.
引用
- Bo YF, Tian RR, Bao LL, et al. [Clinical value of 18F-PSMA-1007 PET/CT combined with serum total prostate specific antigen in predicting International Society of Urological Pathology pathological grading of prostate cancer]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 39939019. doi:10.3760/cma.j.cn112152-20240417-00156
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。